Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4401–4450 of 34692
In connection with the above departures, the Board intends to nominate Vikram Kini to stand for election to the Board at the Annual Meeting (the " Director Nomination ").
On February 11, 2025, Lisa M. Lambert notified the Board of Directors (the " Board ") of UL Solutions Inc. (the " Company ") that she will not stand for election to the Board at the Company’s 2025 annual meeting of stockholders (the " Annual Meeting ").
On February 11, 2025, the Board determined that Frank Coyne will not be nominated for election as a member of the Board at the Annual Meeting, in accordance with the director retirement policy contained in the Company’s Corporate Governance Guidelines.
John A. Ross informed the Company of his intention to retire from the Board of Directors (the “Board”) of the Company, effective as of the close of business on May 22, 2025.
appointed Scott W. Madison as a member of the boards of directors, effective immediately
On February 12, 2025, upon the recommendation of its Corporate Governance and Nominating Committee, the Board of Directors (the “Board”) of Sonoco Products Company (the “Company”) approved an increase to the size of the Board from eleven (11) to twelve (12) directors and appointed Scott A. Clark to the Board.
each member of the Company’s board of directors resigned from and ceased serving
each member of the Company’s board of directors resigned from and ceased serving
William Wise became the sole director of the Company, effective as of the Effective Time.
each member of the Company’s board of directors resigned from and ceased serving
each member of the Company’s board of directors resigned from and ceased serving
each member of the Company’s board of directors resigned from and ceased serving
On February 11, 2025, Connie L. Matsui, a member of the Board of Directors of Halozyme Therapeutics, Inc. (the “Company”), notified the Company of her intention not to stand for reelection at the Company’s 2025 annual meeting of stockholders.
the Company appointed David Liu, the Lead Investor Nominee, to serve on the Board of Directors
On February 10, 2025, David P. Schenkein, M.D., notified Agios Pharmaceuticals, Inc. (the “Company”) of his decision to resign from the Board of Directors of the Company (the “Board”), effective February 28, 2025.
On February 10, 2025, Michael A. Perry resigned as a director of Nuveen Global Cities REIT, Inc. (the “Company”), effective immediately.
On February 12, 2025, Elizabeth (Libby) Spencer informed the Board of Directors (the “Board”) of Willamette Valley Vineyards, Inc. (the “Company”) that she was resigning from the Board effective February 13, 2025, for personal reasons.
Mr. Niel Ransom has been elected as a Class II director of the Company, effective February 1, 2025
On December 31, 2024, Chris Homeister, independent Director of our Company, provided written notice to the Company’s Board of his resignation, effectively immediately.
appointed Helle Thorning-Schmidt and Ralph Hamers to the Board
appointed Helle Thorning-Schmidt and Ralph Hamers to the Board
Neville Joanes was appointed director.
On February 8, 2025, Cathryn Chen resigned as a member of the Board of Directors of DIH Holding US, Inc. (the “Company”) effective upon her resignation.
the Board, on the recommendation of its Nominating and Corporate Governance Committee, appointed Robin Smith director of the Company.
the Board increased the size of the Board from ten (10) directors to eleven (11) directors and appointed James Dinkins as director of the Company, effective February 12, 2025.
Hannah Cho and Hubert Marleau each announced that they will retire from their positions as members of the Board and from all committees, effective immediately.
Hannah Cho and Hubert Marleau each announced that they will retire from their positions as members of the Board and from all committees, effective immediately.
On February 13, 2025, Rebecca L. Steinfort, a member of the board of trustees (the “Board”) of National Storage Affiliates Trust (the “Company”), informed the Board that she will not be standing for re-election to the Board at the Company’s next annual meeting of shareholders, to be held on May 12, 2025 (the “Annual Meeting”).
Thomas Ellis, an affiliate of the Lead Investor, will serve as a Class II Director
On February 10, 2025, the board of directors (the “Board”) of Loop Industries, Inc., a Nevada corporation (the “Company”), elected Mr. Spencer Hart as a member of the Board.
On February 10, 2025, the Board appointed Alex Vander Linde as a director of the Company, effective immediately.
On February 10, 2025, Brian Ruder submitted his resignation as a member of the Board of Directors (the “Board”) of Informatica Inc. (the “Company”), effective immediately.
On February 11, 2025, the Board of Directors of The Southern Company (the “Company”) elected a new director, Mr. James O. (Jimmy) Etheredge, effective as of April 1, 2025.
appointed Zhanna Golodryga to the Board, effective as of April 1, 2025
Charles J. Dockendorff informed Boston Scientific Corporation (the “Company”) that he will not stand for re-election at the Company’s 2025 Annual Meeting of Stockholders
On February 9, 2025, Karen Grimes notified TEGNA Inc. (the “Company”) of her decision to retire from the Company’s Board of Directors (the “Board”) and not to stand for re-election at the Company’s 2025 annual meeting of shareholders (the “2025 Annual Meeting”).
On February 6, 2025, Kathleen Love notified comScore, Inc. (the "Company") of her resignation from the Board of Directors of the Company, effective February 7, 2025.
Additionally, on February 11, 2025, Dr. Wang notified the board of directors (the “Board”) of his resignation as a member of the Board, effective February 11, 2025.
the Board increased the size of the Board from eleven to twelve directors and appointed a new director, Jed Rhoads, to the Board.
Pursuant to the terms of the TD stockholder agreement and the resignation letters, Mr. Levitt and Mr. Masrani resigned from the board of directors of the Company as of the effective date.
Pursuant to the terms of the TD stockholder agreement and the resignation letters, Mr. Levitt and Mr. Masrani resigned from the board of directors of the Company as of the effective date.
On January 22, 2025, Kwong Sang Liu resigned from his position as an independent director of the Board of Directors of the Company (the “ Board ”) and as member of the Nominating and Corporate Governance Committee of the Board, Chairman of the Audit Committee of the Board and member of the Compensation Committee of the Board.
Effective January 22, 2025, the Board appointed Zhelun Zhou as an independent director of the Board and as member of the Nominating and Corporate Governance Committee of the Board, Chairman of the Audit Committee of the Board and member of the Compensation Committee of the Board, to fill the vacancy created by the resignation of Kwong Sang Liu.
On December 21, 2024, the Company reported the appointment of Mr. Lyndon (Lincoln) Hsu to the Company’s Board of Directors.
On February 7, 2025, Christopher J. Valasek resigned as a director of Boxabl Inc. (the “Company”).
On February 6, 2025, Jonathan W. Hinton, a member of the Board of Directors (the "Board") of Southern States Bancshares, Inc. (the "Company") notified the Board that he does not intend to stand for re-election to the Company’s Board following the expiration of his current term.
On February 10, 2025, the Company’s Board of Directors (the “Board”) appointed Alexander Kayyal to the Board as a Class I director, effective February 14, 2025.
On February 11, 2025 , the Board of Directors of Serina Therapeutics, Inc. (the “Company”) appointed Dr. Jay Venkatesan to the Company’s Board of Directors, effective February 12, 2025.
The Company also announced the departure of Dr. Milton Harris from its Board of Directors effective February 11, 2025 .
on February 7, 2025, Dr. John Paglia also notified the Board of his intention to resign as an independent director of the Company and as a member of each committee of the Board on which he served, effective as of March 7, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.